Skip to main content
International Journal of Clinical and Experimental Pathology logoLink to International Journal of Clinical and Experimental Pathology
. 2024 Nov 15;17(11):442–443. doi: 10.62347/WTHX6766

DLC-3 suppresses cellular proliferation, migration, and invasion in triple-negative breast cancer by the Wnt/β-catenin pathway

Bin Kong 1, Zhi-Dong Lv 1, Jing Xia 1, Li-Ying Jin 2, Zhao-Chuan Yang 3
PMCID: PMC11626287  PMID: 39660331

An error was found in Figure 4A and 4B in this article. Therefore, we are providing the correct versions to replace the incorrect figures and accurate reflect changes. This correction does not alter any interpretations or conclusions of the study. We apologize for this oversight and any confusion it may have caused. The corrected Figure 4 is shown below.

Figure 4.

Figure 4

Upregulation of DLC-3 suppresses breast cancer migration and invasion in vitro. A. Compared to the control group, upregulation of DLC-3 significantly inhibited MDA-MB-231 cell migration by wound healing assay. B and C. The number of pcDNA3.1(+)-DLC-3 cells that passed through the membrane was lower than the number in the pcDNA3.1(+) group and the untransfected MDA-MB-231 group (*P < 0.05). No difference was observed between the pcDNA3.1(+) group and the untransfected MDA-MB-231 group.


Articles from International Journal of Clinical and Experimental Pathology are provided here courtesy of e-Century Publishing Corporation

RESOURCES